Search Within

Andrew D Zelenetz

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (79)
  2. Journal Article (72)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (153)
  2. Department of Medicine (153)
  3. Epidemiology and Biostatistics (153)
  4. Hematologic Malignancies, Division of (153)
  5. Lymphoma (153)
  6. Biostatistics Service (127)

More Groups

People
  1. Paul Hamlin (75)
  2. Craig Moskowitz (74)
  3. Anita Kumar (68)
  4. Ariela Noy (67)
  5. Maria Palomba (64)
  6. David Straus (63)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (12)
  4. 2022 (9)
  5. 2021 (15)
  6. 2020 (9)

More Years

Publications
  1. Blood (64)
  2. Journal of Clinical Oncology (17)
  3. Hematological Oncology (11)
  4. Blood Advances (8)
  5. British Journal of Haematology (8)
  6. Haematologica (6)

More Publications

Publishers
  1. American Society of Hematology (72)
  2. American Society of Clinical Oncology (17)
  3. Wiley Blackwell (11)
  4. Nature Publishing Group (9)
  5. John Wiley & Sons (8)
  6. Elsevier Inc. (7)

More Publishers

Results (153)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas
    Meeting Abstract

    Gerecitano, J.; Portlock, C. S.; Hamlin, P. A.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Journal Article

    O'Connor, O. A.; Horwitz, S.; Hamlin, P.; Portlock, C.; Moskowitz, C. H.; Sarasohn, D.; Neylon, E.; Mastrella, J.; Hamelers, R.; Macgregor-Cortelli, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial
    Journal Article

    O'Connor, O. A.; Moskowitz, C.; Portlock, C.; Hamlin, P.; Straus, D.; Dumitrescu, O.; Sarasohn, D.; Gonen, M.; Butos, J.; Neylon, E.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Perales, M. A.; Kewalramani, T.; Yahalom, J.; Castro-Malaspina, H.; Zhang, Z.; Vanak, J.; Zelenetz, A. D.; Moskowitz, C. H.
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
    Journal Article

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    Bone Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma
    Journal Article

    Gerecitano, J.; Portlock, C.; Moskowitz, C.; Hamlin, P.; Straus, D.; Zelenetz, A. D.; Zhang, Z.; Dumitrescu, O.; Sarasohn, D.; Lin, D.; more...
    British Journal of Haematology (2009)

    Fulltext@MSK | Save
  • Influence of post-second-line chemotherapy PET Imaging and involved field radiotherapy prior to high dose therapy on outcomes of relapsed or refractory diffuse large B cell lymphoma
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Kewalramani, T.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity
    Journal Article

    Hoppe, B. S.; Moskowitz, C. H.; Filippa, D. A.; Moskowitz, C. S.; Kewalramani, T.; Zelenetz, A. D.; Yahalom, J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Feasiblity and implication of bidirectional sequencing using a multiplex framework 2 region primer for somatic mutation analysis of the immunoglobulin (IgH) heavy chain in chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Nelson, A.; Rijo, I.; Zhang, Z. G.; Zelenetz, A. D.; Noy, A.
    Blood (2007)

    Fulltext@MSK | Save